Raimund Johannes Ober

Title: Innovations of Raimund Johannes Ober

Introduction

Raimund Johannes Ober is a notable inventor based in College Station, TX (US). He has made significant contributions to the field of biotechnology, particularly in the development of targeted delivery systems for therapeutic agents. With a total of 3 patents, his work focuses on improving the efficacy of drug delivery to specific cellular compartments.

Latest Patents

One of his latest patents is titled "Endolysosomal targeting conjugates for improved delivery of cargo molecules to the endolysosomal compartment of target cells." This invention describes engineered endolysosomal targeting conjugates designed to deliver cargo molecules, such as cytotoxic drugs or imaging labels, with enhanced efficiency to late endosomes and/or lysosomes in target cells, including tumor cells. The conjugate comprises a targeting component that binds to a cell surface molecule of a target cell and a cargo component that includes the cargo molecule. The targeting and cargo components may be linked by either covalent or non-covalent bonds, allowing for higher affinity binding in the extracellular space compared to the endolysosomal compartment.

Another significant patent is "Fusion proteins (Seldegs) for selectively depleting antigen-specific antibodies and methods of use thereof." This patent introduces a fusion protein known as a 'Seldeg,' which includes a targeting component that binds specifically to a cell surface receptor at near-neutral pH, along with an antigen component that is fused to the targeting component. This invention provides a method for depleting target antigen-specific antibodies from patients by administering a Seldeg that binds specifically to the target antibodies.

Career Highlights

Raimund Johannes Ober is affiliated with the University of Texas System, where he continues to advance research in targeted drug delivery systems. His innovative approaches have the potential to significantly impact therapeutic strategies in various medical fields.

Collaborations

Some of his notable coworkers include Elizabeth Sally Ward Ober and Jeffrey Che-Wei Kang, who contribute to the collaborative research efforts within the University of Texas System.

Conclusion

Raimund Johannes Ober's work exemplifies the innovative spirit of modern biotechnology, focusing on enhancing drug delivery systems for improved patient outcomes. His contributions through his patents reflect a commitment to advancing medical science and technology.